ERBB2 and gastric cancer: Although this study could not provide sufficient evidence to enable a clear conclusion to be reached, further investigation of the relationship between HER2 expression and GC histological type, with the molecular mechanism which defines the histological type, may provide insights to expand the indication for HER2 therapies.